China Pharma Holdings (CPHI) EBITDA Margin (QoQ) (2010 - 2026)
China Pharma Holdings (CPHI) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,570.00 |
| Dec 31, 2025 | -1,483.00 |
| Sep 30, 2025 | -1,949.00 |
| Jun 30, 2025 | 319.00 |
| Mar 31, 2025 | 3,871.00 |
| Dec 31, 2024 | -682.00 |
| Sep 30, 2024 | 5,180.00 |
| Jun 30, 2024 | -8,357.00 |
| Mar 31, 2024 | -1,177.00 |
| Dec 31, 2023 | -1,554.00 |
| Sep 30, 2023 | 200.00 |
| Jun 30, 2023 | -2,129.00 |
| Mar 31, 2023 | 1,974.00 |
| Dec 31, 2022 | -499.00 |
| Sep 30, 2022 | 1,330.00 |
| Jun 30, 2022 | 851.00 |
| Mar 31, 2022 | -3,439.00 |
| Dec 31, 2021 | 1,608.00 |
| Sep 30, 2021 | -736.00 |
| Jun 30, 2021 | -164.00 |